2 Top Biotech Picks to Buy and Hold for the Next 10 Years

For an investor focusing on the business, it might only be long enough to hear one quarterly update from management. To keep from getting whiplash, investors in Twist Bioscience (NASDAQ: TWST) and Pacific Biosciences of California (NASDAQ: PACB) will need to be focused on the long-term opportunity for synthetic DNA and long-read genome sequencing, respectively. Each company has a unique position in the life science industry, but short-term volatility could shake the confidence of anyone worried about the stock price over the next year or two.